Abram Scientific DARPA Contract: Bold Win for Rapid Portable Blood-Coagulation Testing
Abram Scientific DARPA contract of up to $8.3M backs CoagCare, a portable clotting test. It is not FDA-cleared; speed claims are the company’s.
Abram Scientific DARPA contract of up to $8.3M backs CoagCare, a portable clotting test. It is not FDA-cleared; speed claims are the company’s.